EMEA-000332-PIP01-08-M15

Table of contents

Key facts

Invented name
  • Briviact (in Italy: Nubriveo)
  • QG01AA01
Active substance
Brivaracetam
Therapeutic area
Neurology
Decision number
P/0324/2020
PIP number
EMEA-000332-PIP01-08-M15
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
  • Solution for injection
Condition(s) / indication(s)
  • Treatment of epilepsy with partial-onset seizures
  • Treatment of neonatal seizures
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
UCB Pharma S.A.

E-mail: UCBCares.IE@ucb.com
Tel. +353 1463 2371
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating